Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

近年来，科学家们发现人体微生物组和各种疾病之间存在着千丝万缕的联系，就如同隐藏在身体里的 “神秘密码”。其中，肠道微生物组与 PH 的关系已经有了一些研究成果，比如发现 PH 患者的肠道微生物组发生了变化，而且肠道微生物群产生的代谢物三甲胺 N - 氧化物（trimethylamine N-oxide），被证明在 PH 患者中富集，阻断它可以抑制大鼠实验性 PH ...

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

Gossamer Bio ( ($GOSS) ) has released its Q4 earnings. Here is a breakdown of the information Gossamer Bio presented to its investors. Gossamer ...

Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing.

Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...

Cash, cash equivalents and marketable securities as of December 31, 2024, were $294.5 million. As a result, we expect our ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...